Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone for prevention of postoperative pancreatitis
NCT01460615Phase 2Completed
- Sponsor
- Tampere University Hospital
- Start
- Feb 2011
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydrocortisone in postoperative pancreatitis (POAP), sponsored by Tampere University Hospital. Started Feb 2011; status: completed.
02
Drugs
hydrocortisone
03
Conditions
postoperative pancreatitis (POAP)
Beyond the preview
Go deeper on NCT01460615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01460615.